Axiom (Biotechnology)

San Francisco, CA · Privately Held (backing)

Developer of a biotechnology platform designed to help scientists predict and mitigate drug toxicity earlier in the development process. Axiom (Biotechnology) is based in San Francisco, CA. Its last reported valuation was $121 million in Apr 2025. It has raised $30 million.

Last reported valuation

$121.0M

Oct 2026

Priced at

—

Total raised

$30.0M

Last round

—

How much has Axiom (Biotechnology) raised?

$30.0Macross 0 recorded rounds

Free account

More of Axiom (Biotechnology) with a free account

·The complete investor list: 14 names
·Watch Axiom (Biotechnology): the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Axiom (Biotechnology) investors

14 investors are on record for Axiom (Biotechnology), including Abstract Ventures, CRV, Jeff Dean and Amplify Partners. By type, the record holds 4 venture capital firms, 1 family office and 1 angel investor.

For fundraisers

Raising for a company like Axiom (Biotechnology)?

14 investors have backed Axiom (Biotechnology).

See all 14 investors →

Frequently asked about Axiom (Biotechnology)

How much has Axiom (Biotechnology) raised?: Axiom (Biotechnology) has raised $30.0M in total across 0 recorded funding rounds.